Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
50%
OVERLAP
BY WEIGHT
16
# OF OVERLAPPING
HOLDINGS
FBT
31
HOLDINGS
53%
ALSO IN PBE
PBE
33
HOLDINGS
55%
ALSO IN FBT
SECTOR DRIFT (FBT minus PBE)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FBT |
Weight in PBE |
Overlap | |
|---|---|---|---|---|
 |
BIOGEN IDEC INC | 3.6% | 4.9% | 3.6% |
|
REGENERON PHARMACEUTICALS | 3.5% | 4.7% | 3.5% |
|
UNITED THERAPEUTICS CORP | 3.5% | 4.5% | 3.5% |
|
AMGEN INC | 3.5% | 4.9% | 3.5% |
|
GILEAD SCIENCES INC | 3.4% | 4.5% | 3.4% |
FBT Overweight Relative to PBE
 |
GENMAB A/S SPONSORED ADR | 3.9% |
 |
ALKERMES PLC | 3.6% |
|
ADMA BIOLOGICS, INC. | 3.5% |
|
BEIGENE LTD. SPONSORED ADR | 3.5% |
 |
ARGENX SE ADR | 3.4% |
|
NEOGENOMICS INC | 3.3% |
|
NATERA INC | 3.3% |
|
TG THERAPEUTICS INC | 3.2% |
|
BRUKER CORP | 3.2% |
|
TARSUS PHARMACEUTICALS, INC. | 3.1% |
FBT Underweight Relative to PBE
|
ROYALTY PHARMA PLC CLASS A | -4.8% |
|
CAREDX, INC. | -3.2% |
|
PTC THERAPEUTICS INC | -3.1% |
|
VERICEL CORPORATION | -3.0% |
|
PROTAGONIST THERAPEUTICS, INC. | -3.0% |
|
BIOCRYST PHARMACEUTICALS INC | -2.8% |
|
SAREPTA THERAPEUTICS INC | -2.8% |
|
ACADIA PHARMACEUTICALS INC | -2.7% |
|
ANAPTYSBIO, INC. | -2.6% |
|
COLLEGIUM PHARMACEUTICAL, INC. | -2.6% |